These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21983135)

  • 21. Innovative and Highly Sensitive Detection of
    Neumann T; Krüger M; Weisemann J; Mahrhold S; Stern D; Dorner MB; Feraudet-Tarisse C; Pöhlmann C; Schulz K; Messelhäußer U; Rimek D; Gessler F; Elßner T; Simon S; Rummel A; Dorner BG
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33917845
    [No Abstract]   [Full Text] [Related]  

  • 22. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Kakutani H; Kondoh M; Saeki R; Fujii M; Watanabe Y; Mizuguchi H; Yagi K
    Eur J Pharm Biopharm; 2010 Jun; 75(2):213-7. PubMed ID: 20226859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
    Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
    Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel tumor-targeted therapy using a claudin-4-targeting molecule.
    Saeki R; Kondoh M; Kakutani H; Tsunoda S; Mochizuki Y; Hamakubo T; Tsutsumi Y; Horiguchi Y; Yagi K
    Mol Pharmacol; 2009 Oct; 76(4):918-26. PubMed ID: 19638534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral tolerance to ovalbumin in mice: induction and long-term persistence unaffected by Staphylococcus aureus enterotoxin B and Clostridium perfringens type A enterotoxin.
    Gaboriau-Routhiau V; Moreau MC
    Pediatr Res; 1997 Oct; 42(4):503-8. PubMed ID: 9380444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice.
    Suzuki H; Nagatake T; Nasu A; Lan H; Ikegami K; Setou M; Hamazaki Y; Kiyono H; Yagi K; Kondoh M; Kunisawa J
    Sci Rep; 2018 Feb; 8(1):2904. PubMed ID: 29440671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4.
    Kyuno D; Kojima T; Ito T; Yamaguchi H; Tsujiwaki M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
    Cell Tissue Res; 2011 Dec; 346(3):369-81. PubMed ID: 22160590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4.
    Takahashi A; Kondoh M; Masuyama A; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Control Release; 2005 Nov; 108(1):56-62. PubMed ID: 16091298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants.
    Robertson SL; Smedley JG; Singh U; Chakrabarti G; Van Itallie CM; Anderson JM; McClane BA
    Cell Microbiol; 2007 Nov; 9(11):2734-55. PubMed ID: 17587331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
    Long H; Crean CD; Lee WH; Cummings OW; Gabig TG
    Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
    Kayamuro H; Abe Y; Yoshioka Y; Katayama K; Nomura T; Yoshida T; Yamashita K; Yoshikawa T; Kawai Y; Mayumi T; Hiroi T; Itoh N; Nagano K; Kamada H; Tsunoda S; Tsutsumi Y
    Biomaterials; 2009 Oct; 30(29):5869-76. PubMed ID: 19646748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant TNF-alpha, mTNF-K90R, is a novel candidate adjuvant for a mucosal vaccine against HIV.
    Kayamuro H; Abe Y; Yoshioka Y; Katayama K; Yoshida T; Yamashita K; Yoshikawa T; Kawai Y; Mayumi T; Hiroi T; Itoh N; Nagano K; Kamada H; Tsunoda S; Tsutsumi Y
    Pharmazie; 2010 Apr; 65(4):254-6. PubMed ID: 20432620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin.
    Masuyama A; Kondoh M; Seguchi H; Takahashi A; Harada M; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y
    J Pharmacol Exp Ther; 2005 Aug; 314(2):789-95. PubMed ID: 15870390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
    Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
    Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin.
    Shrestha A; McClane BA
    mBio; 2013 Jan; 4(1):. PubMed ID: 23322640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of Clostridium perfringens enterotoxin with receptor claudins.
    Shrestha A; Uzal FA; McClane BA
    Anaerobe; 2016 Oct; 41():18-26. PubMed ID: 27090847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction.
    Kimura J; Abe H; Kamitani S; Toshima H; Fukui A; Miyake M; Kamata Y; Sugita-Konishi Y; Yamamoto S; Horiguchi Y
    J Biol Chem; 2010 Jan; 285(1):401-8. PubMed ID: 19903817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proof of concept for claudin-targeted drug development.
    Suzuki H; Kondoh M; Takahashi A; Yagi K
    Ann N Y Acad Sci; 2012 Jul; 1258():65-70. PubMed ID: 22731717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.